Sumanta K. Pal

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial

Padmanee Sharma, Margitta Retz, Arlene O. Siefker‐Radtke et al. · The Lancet Oncology · 2017 · 1.7K citations

Medicine, Oncology, Urology +12

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

David F. McDermott, Mahrukh Huseni, Michael B. Atkins et al. · Nature Medicine · 2018 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +17

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial

Toni K. Choueiri, Bernard Escudier, Thomas Powles et al. · The Lancet Oncology · 2016 · 939 citations · Full text

Medicine, Oncology, Pharmacology +12

Bladder Cancer, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

Thomas W. Flaig, Philippe E. Spiess, Neeraj Agarwal et al. · Journal of the National Comprehensive Cancer Network · 2020 · 628 citations · Full text

Medicine, Oncology, Urology +16

Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study

Saro H. Armenian, Lanfang Xu, Bonnie Ky et al. · Journal of Clinical Oncology · 2016 · 544 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16